全文获取类型
收费全文 | 990篇 |
免费 | 56篇 |
国内免费 | 1篇 |
专业分类
耳鼻咽喉 | 2篇 |
儿科学 | 19篇 |
妇产科学 | 15篇 |
基础医学 | 93篇 |
口腔科学 | 12篇 |
临床医学 | 51篇 |
内科学 | 118篇 |
皮肤病学 | 8篇 |
神经病学 | 187篇 |
特种医学 | 72篇 |
外科学 | 168篇 |
综合类 | 3篇 |
一般理论 | 2篇 |
预防医学 | 18篇 |
眼科学 | 139篇 |
药学 | 50篇 |
中国医学 | 22篇 |
肿瘤学 | 68篇 |
出版年
2024年 | 4篇 |
2023年 | 17篇 |
2022年 | 17篇 |
2021年 | 15篇 |
2020年 | 13篇 |
2019年 | 19篇 |
2018年 | 19篇 |
2017年 | 26篇 |
2016年 | 28篇 |
2015年 | 32篇 |
2014年 | 21篇 |
2013年 | 41篇 |
2012年 | 70篇 |
2011年 | 81篇 |
2010年 | 33篇 |
2009年 | 49篇 |
2008年 | 47篇 |
2007年 | 55篇 |
2006年 | 54篇 |
2005年 | 48篇 |
2004年 | 56篇 |
2003年 | 56篇 |
2002年 | 66篇 |
2001年 | 34篇 |
2000年 | 30篇 |
1999年 | 23篇 |
1998年 | 9篇 |
1997年 | 8篇 |
1996年 | 2篇 |
1995年 | 3篇 |
1994年 | 3篇 |
1992年 | 2篇 |
1991年 | 3篇 |
1990年 | 3篇 |
1989年 | 3篇 |
1988年 | 4篇 |
1987年 | 5篇 |
1986年 | 4篇 |
1985年 | 3篇 |
1984年 | 2篇 |
1975年 | 3篇 |
1968年 | 2篇 |
1966年 | 2篇 |
1962年 | 3篇 |
1961年 | 3篇 |
1912年 | 1篇 |
1904年 | 1篇 |
1903年 | 7篇 |
1900年 | 1篇 |
1891年 | 1篇 |
排序方式: 共有1047条查询结果,搜索用时 15 毫秒
101.
102.
Schneider R Lamade W Hermann M Goretzki P Timmermann W Hauss J Leinung S 《Zentralblatt für Chirurgie》2012,137(1):88-90
103.
104.
Patrick Sadoghi Christian Schr?der Andreas Fottner Arnd Steinbrück Oliver Betz Peter E. Müller Volkmar Jansson Andreas H?lzer 《International orthopaedics》2012,36(11):2197-2203
Purpose
The aim of the study was to compare primary total hip arthroplasty (THA) implantations between different countries in terms of THA number per inhabitant, age, and procedure type and to compare the survival curve including all THAs using hip arthroplasty registers.Methods
THA registers were compared between different countries with respect to the number of primary implantations per inhabitant and age, procedure type and survival curve. We performed a literature search for all national hip arthroplasty registers providing annual reports for 2009 or, if not available, a more recent period. The data from these reports were analysed in terms of number, age distribution and procedure type of primary THAs and survival curves.Results
We identified nine hip arthroplasty registers, which comprised sufficient data to be included. A large variation was found in the annual number of primary THA implantations per inhabitant. The procedure type varied greatly as well, e.g. in Sweden 67 % are cemented THAs whereas in Emilia-Romagna (Italy) 89 % are cementless THAs.Conclusions
This study revealed large differences in terms of the annual number of primary THAs per inhabitant and primary THA procedure type across countries. These data can be used to rank local primary THA implantations within an international context. 相似文献105.
Engel JB Martens T Hahne JC Häusler SF Krockenberger M Segerer S Djakovic A Meyer S Dietl J Wischhusen J Honig A 《Anti-cancer drugs》2012,23(4):426-436
Lobaplatin as a single agent and in combination with tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) is investigated in in-vitro models of p53-negative triple-negative breast cancers (TNBCs) and compared with a model of oestrogen receptor-positive p53-positive breast cancer. In addition, the induction of programmed cell death by lobaplatin is further explored. By using cell viability assays and western blotting, the cytotoxic effects of lobaplatin alone and in combination with TRAIL are compared with cisplatin in HCC 1806, HCC 1937, and MCF 7 cells. The multicaspase inhibitor z-VAD-fmk and necrostatin, an inhibitor of necroptosis, are used to demonstrate the mechanism of cell death caused by lobaplatin. Lobaplatin displayed antitumour activity in all three cell lines, which increased time dependently. Cotreatment of lobaplatin and TRAIL induced an increase in cytotoxicity by 30-50% in the different cell lines. The pan-caspase inhibitor z-VAD-fmk as well as necrostatin could weaken but not abolish the cytotoxic effect of lobaplatin and cisplatin. Lobaplatin showed substantial cytotoxic effects in two in-vitro models of p53-mutated TNBC. Cotreatment with TRAIL and platinum agents resulted in increased antitumour activity in the TNBC cell lines investigated. Cell death subsequent to treatment with cisplatin and lobaplatin occurred because of apoptosis. However, caspase-independent mechanisms of programmed cell death were also involved. It was also demonstrated that platinum compounds could induce necroptosis, although to a minor extent. 相似文献
106.
Ohne Zusammenfassung 相似文献
107.
Dr. Willi Arnd 《Virchows Archiv : an international journal of pathology》1926,261(3):700-731
Ohne ZusammenfassungMit 2 Textabbildungen. 相似文献
108.
Grigoris F. Grimbizis Attilio Di Spiezio Sardo Sotirios H. Saravelos Stephan Gordts Caterina Exacoustos Dominique Van Schoubroeck Carmina Bermejo Nazar N. Amso Geeta Nargund Dirk Timmermann Apostolos Athanasiadis Sara Brucker Carlo De Angelis Marco Gergolet Tin Chiu Li Vasilios Tanos Basil Tarlatzis Roy Farquharson Luca Gianaroli Rudi Campo 《Gynecological surgery》2016,13(1):1-16
What is the recommended diagnostic work-up of female genital anomalies according to the European Society of Human Reproduction and Embryology (ESHRE)/European Society for Gynaecological Endoscopy (ESGE) system? The ESHRE/ESGE consensus for the diagnosis of female genital anomalies is presented. Accurate diagnosis of congenital anomalies still remains a clinical challenge due to the drawbacks of the previous classification systems and the non-systematic use of diagnostic methods with varying accuracy, with some of them quite inaccurate. Currently, a wide range of non-invasive diagnostic procedures are available, enriching the opportunity to accurately detect the anatomical status of the female genital tract, as well as a new objective and comprehensive classification system with well-described classes and sub-classes. The ESHRE/ESGE Congenital Uterine Anomalies (CONUTA) Working Group established an initiative with the goal of developing a consensus for the diagnosis of female genital anomalies. The CONUTA working group and imaging experts in the field have been appointed to run the project. The consensus is developed based on (1) evaluation of the currently available diagnostic methods and, more specifically, of their characteristics with the use of the experts panel consensus method and of their diagnostic accuracy performing a systematic review of evidence and (2) consensus for (a) the definition of where and how to measure uterine wall thickness and (b) the recommendations for the diagnostic work-up of female genital anomalies, based on the results of the previous evaluation procedure, with the use of the experts panel consensus method. Uterine wall thickness is defined as the distance between interostial line and external uterine profile at the midcoronal plane of the uterus; alternatively, if a coronal plane is not available, the mean anterior and posterior uterine wall thickness at the longitudinal plane could be used. Gynaecological examination and two-dimensional ultrasound (2D US) are recommended for the evaluation of asymptomatic women. Three-dimensional ultrasound (3D US) is recommended for the diagnosis of female genital anomalies in “symptomatic” patients belonging to high-risk groups for the presence of a female genital anomaly and in any asymptomatic woman suspected to have an anomaly from routine avaluation. Magnetic resonance imaging (MRI) and endoscopic evaluation are recommended for the sub-group of patients with suspected complex anomalies or in diagnostic dilemmas. Adolescents with symptoms suggestive for the presence of a female genital anomaly should be thoroughly evaluated with 2D US, 3D US, MRI and endoscopy. The various diagnostic methods should be used in a proper way and evaluated by experts to avoid mis-, over- and underdiagnosis. The role of a combined ultrasound examination and outpatient hysteroscopy should be prospectively evaluated. It is a challenge for further research, based on diagnosis, to objectively evaluate the clinical consequences related to various degrees of uterine deformity. 相似文献
109.
Influence of donor MHC class I antigen expression on graft survival after rat parathyroid allotransplantation 总被引:1,自引:0,他引:1
S. Timm W. Hamelmann C. Otto A. Gassel M. Etzel K. Ulrichs A. Thiede W. Timmermann 《Langenbeck's archives of surgery / Deutsche Gesellschaft fur Chirurgie》2001,386(6):430-433
BACKGROUND AND AIMS: We investigated the influence of donor MHC antigen expression on graft survival after parathyroid transplantation in three different strain combinations. METHODS: MHC class I and II expression on parathyroid tissue of Lewis (LEW), Dark Agouti (DA), and Wistar-Furth (WF) rats was first analysed semiquantitatively by immunohistochemistry. Additionally, five groups were transplanted: (1) LEW to LEW, (2) DA to DA, (3) LEW to DA, (4) WF to LEW, and (5) DA to LEW. METHODS: MHC class I expression was strong in DA, moderate in WF, and weak in LEW rats; MHC class II expression was negative in all three strains. In the interstitium of all investigated tissue specimens, the proportion of MHC class II-expressing cells was low. RESULTS: After syngeneic transplantation, graft survival could be documented over the whole observation period. A mean graft survival of 20 (+/-2) days was observed following transplantation from LEW to DA, grafts in the group WF to LEW were rejected after 13 (+/-1) days, and graft function lasted 8 (+/-2) days in the group DA to LEW. The number of intragraft leukocytes expressing MHC class II molecules was equal in all groups, whereas increased levels of MHC class I on rat parathyroid tissue before transplantation resulted in a more rapid rejection. CONCLUSION: These results demonstrate that immunogenicity of rat parathyroid tissue seems to be determined by the amount of MHC class I expressed on donor parenchymal cells. 相似文献
110.